<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Bronchiectasis in children: Pathophysiology and causes
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Bronchiectasis in children: Pathophysiology and causes
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Bronchiectasis in children: Pathophysiology and causes
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vikas Goyal, MBBS, DCH, FRACP, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anne B Chang, MBBS, FRACP, PhD, FAPSR, FAHMS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            James F Chmiel, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 07, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchiectasis in children is defined as the presence of abnormal bronchial dilatation on computed tomography (CT) scans, in combination with a clinical syndrome of recurrent or persistent wet/productive cough, airway infection, and/or inflammation infections [
         <a href="#rid1">
          1,2
         </a>
         ]. It is the end result of a variety of pathophysiologic processes that involve chronic or recurrent infection and airway obstruction and/or impaired mucociliary clearance, resulting in a vicious cycle that causes progressive damage to the bronchial walls.
        </p>
        <p>
         In resource-abundant/high-income settings, cystic fibrosis (CF) is the most common condition leading to bronchiectasis. The evaluation and management of CF-related bronchiectasis is discussed in detail in separate topic reviews. (See
         <a class="medical medical_review" href="/z/d/html/6369.html" rel="external">
          "Cystic fibrosis: Clinical manifestations of pulmonary disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6372.html" rel="external">
          "Cystic fibrosis: Overview of the treatment of lung disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/129117.html" rel="external">
          "Cystic fibrosis: Management of advanced lung disease"
         </a>
         .)
        </p>
        <p>
         The pathogenesis and causes of bronchiectasis in children are outlined below. The evaluation and treatment of bronchiectasis in children without CF are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6360.html" rel="external">
          "Bronchiectasis in children: Clinical manifestations and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6355.html" rel="external">
          "Bronchiectasis in children without cystic fibrosis: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchiectasis was once considered rare in children but is increasingly recognized over the last two decades, likely due to increasing awareness of the condition and availability of sensitive diagnostic methods [
         <a href="#rid3">
          3
         </a>
         ]. In particular, multidetector high-resolution CT (HRCT) is now widely available and can detect milder disease compared with less sensitive forms of radiography (eg, HRCT alone or plain chest radiographs) [
         <a href="#rid4">
          4,5
         </a>
         ]. In addition, case identification is enhanced by using pediatric criteria for radiographic diagnosis compared with adult criteria [
         <a href="#rid3">
          3,6,7
         </a>
         ]. The importance of this chronic disease and its burden in both adults and children are now recognized [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         The incidence of bronchiectasis in children is highly variable, ranging from 0.2 to 735 per 100,000 children annually, based on extrapolation of published data [
         <a href="#rid9">
          9
         </a>
         ]. Bronchiectasis affects children from low-, middle-, and high-income countries [
         <a href="#rid9">
          9
         </a>
         ]. For example, reported incidence of bronchiectasis in children aged 0 to 14 years old ranges from 0.2 per 100,000 child-years in England to 3.7 per 100,000 child-years in New Zealand [
         <a href="#rid9">
          9-11
         </a>
         ]. In a study from the United States, bronchiectasis unrelated to cystic fibrosis (CF) was diagnosed in 4.2 per 100,000 young adults [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         The prevalence of bronchiectasis is likely higher than that reported in populations with limited resources and high frequency of respiratory infections [
         <a href="#rid9">
          9,13-15
         </a>
         ]. In children, the highest published prevalence of bronchiectasis is from several indigenous populations, including natives of Polynesia, Alaska, Australia, and New Zealand, where it is as high as 15 per 1000 children [
         <a href="#rid13">
          13,16,17
         </a>
         ]. The incidence of severe bronchiectasis (based on hospitalization) among children in New Zealand was 11.8 per 100,000, with the highest rates among the Māori and Pacific people [
         <a href="#rid18">
          18
         </a>
         ]. The relatively high rates of bronchiectasis in these populations have been attributed to environmental conditions that are associated with recurrent respiratory infections during childhood, such as air pollution (indoor and outdoor), overcrowding, poor hygiene, and limited access to health care. In some cases, a predisposition to bronchiectasis might be related to heritable defects in immunity or pulmonary clearance [
         <a href="#rid16">
          16,19,20
         </a>
         ]. In other populations, a high prevalence of bronchiectasis is due to endemic diseases such as tuberculosis [
         <a href="#rid14">
          14
         </a>
         ]. Tuberculosis remains prevalent in many low- and middle-income countries but is rare in high-income countries [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         Mortality trends due to bronchiectasis have changed with time and depend upon the availability of optimal clinical care [
         <a href="#rid21">
          21
         </a>
         ]. In New Zealand, a 2011 report described fatal outcomes in 6 percent of children with bronchiectasis managed in a tertiary center [
         <a href="#rid22">
          22
         </a>
         ], while a 2020 report described no deaths in children under 15 years of age [
         <a href="#rid18">
          18
         </a>
         ]. Similarly, in Australia and the United States, pediatric deaths related to bronchiectasis are now rare [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         – Bronchiectasis is the result of the interplay between various factors:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Host factors – Patient's age, swallowing and pulmonary function, immune function, genetics and epigenetics
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Environmental factors – Exposure to inhaled or aspirated pathogens and environmental pollutants
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Local pulmonary factors – Airflow limitation or obstruction [
         <a href="#rid25">
          25
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infection – With related inflammation, neutrophil infiltration, and tissue destruction
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormal mucous composition and impaired clearance [
         <a href="#rid26">
          26-28
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The relative contributions of these factors vary. Factors that promote infection, especially environmental exposures or airway obstruction, are central to many cases of bronchiectasis in children. In some cases, primary immunodeficiency or subtle immune dysregulation (eg, impaired immune response to nontypeable
         <em>
          Haemophilus influenzae
         </em>
         ) play a role [
         <a href="#rid29">
          29-31
         </a>
         ]. These processes tend to result in a vicious cycle, in which chronic or recurrent lower airway infection causes inflammation, leading to impaired mucociliary clearance, which, in turn, promotes bacterial colonization and infection, causing progressive damage to the lower airway structure and worsening bronchiectasis [
         <a href="#rid32">
          32
         </a>
         ]. An important example in children is recurrent protracted bacterial bronchitis (PBB), in which chronic lower airway infection can progress to bronchiectasis, which is initially reversible but eventually becomes irreversible unless the cycle is interrupted by appropriate antibiotic treatment and airway clearance therapies  (
         <a class="graphic graphic_figure graphicRef115194" href="/z/d/graphic/115194.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid33">
          33,34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6356.html" rel="external">
          "Causes of chronic cough in children", section on 'Chronic endobronchial suppurative disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Molecular mechanisms that contribute to airway damage in bronchiectasis are discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/1444.html" rel="external">
          "Clinical manifestations and diagnosis of bronchiectasis in adults", section on 'Pathophysiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Histopathology
         </strong>
         – Key histopathologic features in bronchiectasis are dilation and inflammation of the bronchial wall, particularly in the peripheral airways. Early changes include bronchial wall edema and destruction of elastin, which eventually leads to destruction of nearby muscle and cartilage and progressive bronchial dilation [
         <a href="#rid35">
          35
         </a>
         ]. Biopsies of bronchial mucosa show tissue neutrophilia with increased interleukin 8 expression, mononuclear cell infiltrate (composed mainly of CD4+ T cells and CD68+ macrophages), mucous gland hypertrophy, and increased airway smooth muscle mass [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gross appearance
         </strong>
         – The gross features of bronchiectasis in children are often classified according to the classic Reid classification used for adults [
         <a href="#rid38">
          38
         </a>
         ], based on the appearance on imaging  (
         <a class="graphic graphic_figure graphicRef139531" href="/z/d/graphic/139531.html" rel="external">
          figure 2
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cylindrical – Smooth tubular dilation of the bronchi
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Varicose (or fusiform) – Bronchi are dilated with multiple indentations (narrowed segments)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cystic (or saccular) – Dilated bronchi terminate in blind-ending sacs
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         High-resolution CT (HRCT) scoring systems utilize cylindrical and cystic changes as markers of disease severity [
         <a href="#rid38">
          38
         </a>
         ]. In children in high-income countries where there is good access to imaging, cylindrical bronchiectasis is most common [
         <a href="#rid39">
          39
         </a>
         ]. Several studies suggest that cylindrical bronchiectasis may be reversible if the underlying cause is successfully treated, while later stages of bronchiectasis may be irreversible but can still improve with optimal treatment [
         <a href="#rid40">
          40,41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6360.html" rel="external">
          "Bronchiectasis in children: Clinical manifestations and evaluation", section on 'Imaging'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CAUSES OF BRONCHIECTASIS IN CHILDREN
         </span>
        </p>
        <p class="headingAnchor" id="H2528050765">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         The main causes of bronchiectasis in children are listed in the table  (
         <a class="graphic graphic_table graphicRef87712" href="/z/d/graphic/87712.html" rel="external">
          table 1
         </a>
         ). These are similar to the causes of bronchiectasis in adults but with a higher proportion of congenital immune defects or structural anomalies. Identifying specific treatable causes of bronchiectasis can delay progression or even reverse bronchiectasis in some cases [
         <a href="#rid7">
          7,42-44
         </a>
         ]. In a majority of adults with bronchiectasis, the disease process began during childhood but was not recognized until much later in life [
         <a href="#rid45">
          45-47
         </a>
         ]. Adults with childhood onset of symptoms have more severe bronchiectasis and poorer outcomes compared with those with adult-onset symptoms.
        </p>
        <p>
         In a literature review that included almost 1000 children with bronchiectasis, 63 percent had an identified predisposing condition (including 19 percent with protracted bacterial bronchiectasis or other infections) [
         <a href="#rid48">
          48
         </a>
         ]. However, the prevalence and nature of underlying conditions vary depending on the population studied and intensity of evaluation [
         <a href="#rid9">
          9,49,50
         </a>
         ]. Accordingly, infectious causes such as tuberculosis, pertussis, and measles [
         <a href="#rid13">
          13,51
         </a>
         ] are likely to predominate where these conditions are still prevalent, whereas causes such as oropharyngeal aspiration (with underlying neuromuscular or swallowing disorders), allergic bronchopulmonary aspergillosis (ABPA), and immunodeficiency are more likely to be identified in resource-abundant settings where intensive diagnostic methods are available and utilized [
         <a href="#rid42">
          42,44,52,53
         </a>
         ]. Registry data from Australia report that infective/idiopathic bronchiectasis is, by far, the most common cause of bronchiectasis (84 percent), followed by immunodeficiency (4 percent), recurrent small-volume aspiration (4 percent), and primary ciliary dyskinesia (PCD; 3 percent); foreign body aspiration accounted for only 1 percent of cases in this cohort [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         Bronchiectasis is sometimes classified by its anatomic distribution (generalized versus focal/segmental). Generalized bronchiectasis is typically seen in cases with an underlying systemic disease or condition, whereas focal bronchiectasis is usually the end result of a localized disease process such as bronchial obstruction  (
         <a class="graphic graphic_table graphicRef71732" href="/z/d/graphic/71732.html" rel="external">
          table 2
         </a>
         ). This anatomic classification can help to target the evaluation and investigations but is not a reliable predictor of the underlying diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/6360.html" rel="external">
          "Bronchiectasis in children: Clinical manifestations and evaluation"
         </a>
         .)
        </p>
        <p>
         The discussion below outlines key causes of bronchiectasis in children, grouped by primary mechanism.
        </p>
        <p class="headingAnchor" id="H1679222558">
         <span class="h2">
          Postinfectious conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         In socially disadvantaged populations or in resource-limited settings, chronic or untreated respiratory infections are a common cause of bronchiectasis in children [
         <a href="#rid54">
          54,55
         </a>
         ]. By contrast, in resource-abundant settings, infection is not as common a cause of bronchiectasis unless there is an underlying anatomic or immunologic defect. The key causes are listed below.
        </p>
        <p class="headingAnchor" id="H377520675">
         <span class="h3">
          Protracted bacterial bronchitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Protracted bacterial bronchitis (PBB) is increasingly recognized as a contributor to chronic lung disease in young children worldwide, including certain indigenous populations in Australia, New Zealand, and Alaska [
         <a href="#rid56">
          56
         </a>
         ]. It is characterized by chronic wet cough and bronchial infection with common respiratory pathogens. Identification and treatment of PBB is important because it may be a precursor to chronic suppurative lung disease, including bronchiectasis  (
         <a class="graphic graphic_figure graphicRef115194" href="/z/d/graphic/115194.html" rel="external">
          figure 1
         </a>
         ). Two prospective longitudinal cohort studies described a link between PBB and bronchiectasis in young children, especially those with recurrent PBB (&gt;3 episodes year) and
         <em>
          H
         </em>
         .
         <em>
          influenzae
         </em>
         infection in lower airway cultures [
         <a href="#rid57">
          57,58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6356.html" rel="external">
          "Causes of chronic cough in children", section on 'Protracted bacterial bronchitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3816816762">
         <span class="h3">
          Specific pathogens
         </span>
         <span class="headingEndMark">
          —
         </span>
         Specific pathogens that have been associated with bronchiectasis during childhood include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pertussis and measles
         </strong>
         – Childhood infections with pertussis and measles have been associated with the development of bronchiectasis [
         <a href="#rid59">
          59,60
         </a>
         ]. These childhood infections are uncommon since the advent of routine vaccinations but occasionally occur in unvaccinated children. In a series of 23 children from Italy with bronchiectasis, six cases (26 percent) were triggered by measles or pertussis, all in unvaccinated children [
         <a href="#rid61">
          61
         </a>
         ]. The initial infection occurred at a mean age of 3.6 years and was followed by recurrent pneumonias, ultimately leading to bronchiectasis. (See
         <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">
          "Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Complications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5995.html" rel="external">
          "Pertussis infection in infants and children: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adenovirus
         </strong>
         – Adenovirus infection in early life has been associated with bronchiectasis. A retrospective study of 193 Canadian children admitted to a hospital with adenovirus infection identified eight cases of bronchiectasis in long-term follow-up [
         <a href="#rid62">
          62
         </a>
         ]. Adenovirus in early infancy has been associated with the development of Swyer-James syndrome (described below). In the bronchoalveolar lavage of children with bronchiectasis and PBB, human adenovirus C was the most common strain identified [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mycoplasma
         </strong>
         – Mycoplasma pneumonia usually has a benign course. However, in a series of 38 children hospitalized with mycoplasma pneumonia, eight were found to have bronchiectasis when evaluated with high-resolution CT (HRCT) scan in long-term follow-up [
         <a href="#rid64">
          64
         </a>
         ]. A separate case series described 17 children who developed bronchiolitis obliterans and central bronchiectasis (ie, bronchiectasis involving the large airways) diagnosed between two and eight months after mycoplasma pneumonia [
         <a href="#rid65">
          65
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mycobacteria
         </strong>
         – Tuberculosis remains an important cause of bronchiectasis in children from endemic countries and in children with human immunodeficiency virus (HIV) infection [
         <a href="#rid13">
          13,66,67
         </a>
         ]. The mechanisms include hilar adenopathy (causing obstructive bronchiectasis) and parenchymal disease and fibrosis (causing traction bronchiectasis) [
         <a href="#rid66">
          66,68
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8007.html" rel="external">
          "Tuberculosis disease in children: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications", section on 'Bronchiectasis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Mycobacterium avium-intracellulare complex, an opportunistic infection usually associated with immunodeficiencies or cystic fibrosis (CF), results in lung pathology including adenopathy, cavitation, and bronchiectasis [
         <a href="#rid69">
          69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3755.html" rel="external">
          "Mycobacterium avium complex (MAC) infections in persons with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3938612878">
         <span class="h3">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other patterns of postinfectious bronchiectasis include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bacterial pneumonia
         </strong>
         – Bacterial pneumonia occasionally leads to bronchiectasis, particularly if it is recurrent or associated with an underlying anatomic or immune defect. A case control study in First Nations children in Australia found a strong association between pneumonia requiring hospitalization and bronchiectasis (odds ratio [OR] 15.2, 95% CI 4.4-52.7) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postinfectious bronchiolitis obliterans (PIBO)
         </strong>
         – Bronchiolitis obliterans describes a pattern of histologic abnormalities affecting the small airways, characterized by large-airway bronchiectasis and fibroproliferative thickening of the bronchiolar walls that narrows the bronchiolar lumen and may progress to the complete obliteration of bronchioles. In children, the most common cause is postinfection, which has been particularly described after adenovirus and, less commonly, with mycoplasma pneumonia [
         <a href="#rid71">
          71-73
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6381.html" rel="external">
          "Classification of diffuse lung disease (interstitial lung disease) in infants and children", section on 'Bronchiolitis obliterans'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4323.html" rel="external">
          "Overview of bronchiolar disorders in adults", section on 'Definitions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Bronchiolitis obliterans also can be a complication after transplantation. (See
         <a class="local">
          'Systemic autoimmune or inflammatory disorders'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Swyer-James syndrome
         </strong>
         – Swyer-James syndrome, (also known as unilateral hyperlucent lung) is a subset of PIBO and characterized by decreased pulmonary vascularity and hyperinflation that may be confined to one lung or one lobe, with or without bronchiectasis. It was initially thought to be a congenital anomaly but is now recognized as a postinfectious form of bronchiolitis obliterans that can be caused by a variety of infections occurring during infancy or childhood, including adenovirus and measles. (See
         <a class="medical medical_review" href="/z/d/html/6350.html" rel="external">
          "Congenital lobar emphysema", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2638280218">
         <span class="h2">
          Bronchial narrowing or obstruction
         </span>
        </p>
        <p class="headingAnchor" id="H3186618715">
         <span class="h3">
          Congenital abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Causes of congenital airway or bronchial obstruction include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital airway malacia (tracheomalacia and bronchomalacia)
         </strong>
         – Tracheomalacia and bronchomalacia can be caused by primary defects in the airway wall or may be secondary to external compression by another structure, such as a vascular ring/sling or pulmonary artery dilatation. If the obstruction is severe, it can lead to recurrent infections and bronchiectasis. A case-control study confirmed an association of tracheomalacia with bronchiectasis; the adjusted OR was 13.2 (95% CI 3.2-55) when tracheomalacia was defined by bronchoscopy and 24.4 (95% CI 3.4 to infinity) when European Respiratory Society criteria were used [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6377.html" rel="external">
          "Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula", section on 'Bronchomalacia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6377.html" rel="external">
          "Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula", section on 'Tracheomalacia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other congenital anomalies
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Tracheal or bronchial stenosis (see
         <a class="medical medical_review" href="/z/d/html/6377.html" rel="external">
          "Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bronchogenic cyst (see
         <a class="medical medical_review" href="/z/d/html/6377.html" rel="external">
          "Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula", section on 'Bronchogenic cyst'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Tracheal bronchus (ectopic bronchus) (see
         <a class="medical medical_review" href="/z/d/html/6377.html" rel="external">
          "Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula", section on 'Tracheal bronchus'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bronchopulmonary sequestration (intralobar type) (see
         <a class="medical medical_review" href="/z/d/html/6341.html" rel="external">
          "Bronchopulmonary sequestration"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Congenital pulmonary airway malformation, formerly known as congenital cystic adenomatoid malformation (see
         <a class="medical medical_review" href="/z/d/html/6346.html" rel="external">
          "Congenital pulmonary airway malformation"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Congenital lobar emphysema (see
         <a class="medical medical_review" href="/z/d/html/6350.html" rel="external">
          "Congenital lobar emphysema"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H627356787">
         <span class="h3">
          Foreign body aspiration
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common cause of focal bronchiectasis in previously healthy children is endobronchial obstruction due to foreign body aspiration [
         <a href="#rid75">
          75
         </a>
         ]. Foreign body aspiration is commonly seen in infants and younger children and often involves food items that are not radiopaque, such as peanuts. It typically presents with sudden onset of choking or cough. If the aspiration event is not recognized, the child may present with chronic wet cough weeks or even months after the aspiration event, so the caregivers may not recall a history of choking. If the foreign body is not identified and removed, postobstructive pneumonia and bronchiectasis may develop, sometimes complicated by pneumothorax or hemoptysis [
         <a href="#rid75">
          75-77
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6382.html" rel="external">
          "Airway foreign bodies in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H289708097">
         <span class="h3">
          Endobronchial obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of other disorders tends to cause mucus plugging, including postoperative atelectasis and asthma. If the plugging is prolonged or recurrent, it can lead to bronchiectasis. Disorders mediated by mucoid impaction are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Middle lobe syndrome
         </strong>
         – Middle lobe syndrome is a pattern of chronic or recurrent atelectasis that usually affects the right, middle, or left lingular lobes of the lung. It is sometimes seen in children with asthma who recover from an acute exacerbation with improved respiratory symptoms, but the atelectatic lobe does not reexpand, because of mucous impaction and airway obstruction. This leads to repeated episodes of obstruction, infection, and inflammation that may eventually lead to bronchiectasis in that area [
         <a href="#rid78">
          78-80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6983.html" rel="external">
          "Radiologic patterns of lobar atelectasis", section on 'Right middle lobe'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6378.html" rel="external">
          "Atelectasis in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          ABPA
         </strong>
         – This is a pulmonary hypersensitivity reaction to
         <em>
          Aspergillus
         </em>
         <em>
          fumigatus
         </em>
         that causes intense chronic airway inflammation. Repeated episodes of inflammation, mucoid impaction, and bronchial obstruction can lead to central bronchiectasis, fibrosis, and respiratory compromise. This disorder typically occurs in patients with asthma or CF [
         <a href="#rid81">
          81
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2419.html" rel="external">
          "Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bronchocentric granulomatosis
         </strong>
         – This is a destructive, granulomatous lesion of the bronchi and bronchioles that is generally believed to represent a nonspecific response to a variety of types of airway injury. Approximately one-half of all cases are associated with ABPA. (See
         <a class="medical medical_review" href="/z/d/html/4322.html" rel="external">
          "Bronchocentric granulomatosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Very rarely, endobronchial tumors in children can lead to obstructive bronchiectasis.
        </p>
        <p class="headingAnchor" id="H470255857">
         <span class="h3">
          External airway compression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary granulomatous diseases, particularly tuberculosis or histoplasmosis, can cause bronchiectasis, in part due to extrinsic compression of a bronchus by enlarged lymph nodes, as well as other mechanisms. (See
         <a class="local">
          'Postinfectious conditions'
         </a>
         above.)
        </p>
        <p>
         Severe scoliosis can rarely lead to bronchiectasis due to external compression of the airways [
         <a href="#rid82">
          82
         </a>
         ]. Rare causes of external bronchial compression include lung masses or vascular compression. (See
         <a class="medical medical_review" href="/z/d/html/1444.html" rel="external">
          "Clinical manifestations and diagnosis of bronchiectasis in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1773745241">
         <span class="h2">
          Immunodeficiencies
         </span>
        </p>
        <p class="headingAnchor" id="H313301143">
         <span class="h3">
          Hereditary
         </span>
         <span class="headingEndMark">
          —
         </span>
         Primary immunodeficiency disorders predispose the host to recurrent sinopulmonary infections and to the development of bronchiectasis. Early identification of these immunodeficiencies can prevent progression or even reverse the bronchiectasis [
         <a href="#rid44">
          44
         </a>
         ]. The type of pulmonary infection varies depending on the nature of the immunodeficiency. (See
         <a class="medical medical_review" href="/z/d/html/5949.html" rel="external">
          "Approach to the child with recurrent infections"
         </a>
         .)
        </p>
        <p>
         Conditions causing primary immunodeficiency are discussed elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immunoglobulin (Ig) deficiencies
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         X-linked agammaglobulinemia (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F300755&amp;token=tEpDslnpc0F0kICl%2Fz7sFfZgq3tROP1vh4DhckKBw6HrS5UN%2BLwxUvub6FjLE5Ey&amp;TOPIC_ID=6358" target="_blank">
          MIM #300755
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/3931.html" rel="external">
          "Agammaglobulinemia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         IgG subclass deficiencies (see
         <a class="medical medical_review" href="/z/d/html/3914.html" rel="external">
          "Primary humoral immunodeficiencies: An overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Common variable immunodeficiency (see
         <a class="medical medical_review" href="/z/d/html/16132.html" rel="external">
          "Common variable immunodeficiency in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Selective IgA deficiency (bronchiectasis is uncommon but reported [
         <a href="#rid83">
          83,84
         </a>
         ]) (see
         <a class="medical medical_review" href="/z/d/html/3963.html" rel="external">
          "Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis", section on 'Sinopulmonary'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Combined immunodeficiencies
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe combined immunodeficiency (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F300400&amp;token=tEpDslnpc0F0kICl%2Fz7sFfZgq3tROP1vh4DhckKBw6EdDrpl7E%2FXRWVfzud%2FaBQV&amp;TOPIC_ID=6358" target="_blank">
          MIM #300400
         </a>
         and others) (see
         <a class="medical medical_review" href="/z/d/html/3955.html" rel="external">
          "Severe combined immunodeficiency (SCID): An overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other combined immunodeficiencies (see
         <a class="medical medical_review" href="/z/d/html/3935.html" rel="external">
          "Combined immunodeficiencies: An overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         DiGeorge syndrome (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F188400&amp;token=tEpDslnpc0F0kICl%2Fz7sFXxTtDrQ8uhb%2FIsv0F895ncjFGGl6ypOEDQLWorytTra&amp;TOPIC_ID=6358" target="_blank">
          MIM #188400
         </a>
         ) or velocardiofacial syndrome (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F192430&amp;token=tEpDslnpc0F0kICl%2Fz7sFQdsXnRDd5WxpnJNX2h2G8P%2BZTaa%2Fq6iwZl2Z8iqDnum&amp;TOPIC_ID=6358" target="_blank">
          MIM #192430
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/83396.html" rel="external">
          "DiGeorge (22q11.2 deletion) syndrome: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ataxia-telangiectasia (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F208900&amp;token=tEpDslnpc0F0kICl%2Fz7sFQlT4PDJk22CgmDETGZDOHs57s0u%2B1Ay20nQF115w6d%2B&amp;TOPIC_ID=6358" target="_blank">
          MIM #208900
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6233.html" rel="external">
          "Ataxia-telangiectasia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Major histocompatibility complex deficiencies, which cause bare lymphocyte syndrome (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F604571&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyqqC0U9HEky5TogfQ1PLiC8&amp;TOPIC_ID=6358" target="_blank">
          MIM #604571
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/3956.html" rel="external">
          "CD3/T cell receptor complex disorders causing immunodeficiency", section on 'MHC (HLA) class I deficiency'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Leukocyte dysfunction – Chronic granulomatous disease and other disorders causing leukocyte dysfunction (see
         <a class="medical medical_review" href="/z/d/html/3913.html" rel="external">
          "Primary disorders of phagocyte number and/or function: An overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complement deficiencies (see
         <a class="medical medical_review" href="/z/d/html/3962.html" rel="external">
          "Inherited disorders of the complement system"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H511495999">
         <span class="h3">
          Acquired
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acquired immunodeficiencies can lead to bronchiectasis through the same cycle of recurrent infection, inflammation, and progressive damage to the lower airway structure. Examples include HIV [
         <a href="#rid85">
          85,86
         </a>
         ] and any pharmacologic immunosuppression, including after solid organ transplant [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3798698243">
         <span class="h2">
          Impaired mucociliary clearance
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the following disorders, impaired mucociliary clearance is a primary mechanism that predisposes to recurrent pulmonary infection and leads to bronchiectasis. Because these disorders usually affect the entire airway, the infection and bronchiectasis tend to be diffusely distributed.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          CF
         </strong>
         – CF is the most common genetic cause of bronchiectasis in children and adults in resource-abundant countries. Mutations in the
         <em>
          CFTR
         </em>
         gene (CF transmembrane conductance regulator) result in abnormal ion and water transport across the respiratory epithelial cell, resulting in thick, desiccated mucus and causing chronic airway obstruction, infection, and an excessive host inflammatory response. (See
         <a class="medical medical_review" href="/z/d/html/6369.html" rel="external">
          "Cystic fibrosis: Clinical manifestations of pulmonary disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6372.html" rel="external">
          "Cystic fibrosis: Overview of the treatment of lung disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/129117.html" rel="external">
          "Cystic fibrosis: Management of advanced lung disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Whether the carrier state for CF predisposes to developing bronchiectasis is uncertain, but some data have suggested that there may be an association. In a study of more than 100,000 Danish individuals, among which 3 percent were carriers for heterozygous for the
         <em>
          CFTR
         </em>
         F508del mutation, carriers had a hazard ratio of 1.88 (95% CI 1.03–3.45) for bronchiectasis [
         <a href="#rid88">
          88
         </a>
         ]. Similarly, in a case-control study, carriers of a
         <em>
          CFTR
         </em>
         mutation had a fivefold increase in risk of developing bronchiectasis (OR 5.62, 95% CI 3.85-8.21) [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          PCD
         </strong>
         – PCD (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F244400&amp;token=tEpDslnpc0F0kICl%2Fz7sFZDxK7ki9TNJyVXNO7kDVoMEavSnQKnbrhz%2FP3h%2FwvfF&amp;TOPIC_ID=6358" target="_blank">
          MIM # 244400
         </a>
         and others) is a disorder of ciliary function due to ultrastructural defects or functional abnormality of motile cilia, leading to impaired mucociliary clearance in the airway. PCD can be associated with male infertility and organ laterality defects; the combination of PCD and situs inversus is known as Kartagener syndrome. Children typically present with recurrent sinusitis, complex otitis media, and recurrent pneumonia. Bronchiectasis ultimately develops in most of these patients. (See
         <a class="medical medical_review" href="/z/d/html/4338.html" rel="external">
          "Primary ciliary dyskinesia (immotile-cilia syndrome)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Young syndrome
         </strong>
         – Young syndrome (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F279000&amp;token=tEpDslnpc0F0kICl%2Fz7sFbhJ8i4i2PcUPvJ4%2FzB1yQaoOQULzJCaVWSpKtHKdPxp&amp;TOPIC_ID=6358" target="_blank">
          MIM 279000
         </a>
         ) is characterized by obstructive azoospermia and sinopulmonary infections but no evidence of CF, ciliary dysfunction, or structural defect [
         <a href="#rid90">
          90
         </a>
         ]. Mucociliary clearance is impaired, and bronchiectasis has been reported. This diagnosis is now extremely rare, perhaps because some cases attributed to Young syndrome in the past are now diagnosed as a variant of CF or PCD. (See
         <a class="medical medical_review" href="/z/d/html/1444.html" rel="external">
          "Clinical manifestations and diagnosis of bronchiectasis in adults", section on 'Young syndrome'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6367.html" rel="external">
          "Cystic fibrosis: Clinical manifestations and diagnosis", section on 'CFTR-related disorder'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In addition, airway inflammation (due to infection or other disorder) interferes with mucociliary function and contributes to the pathogenesis of bronchiectasis. (See
         <a class="local">
          'Pathophysiology'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H4263779255">
         <span class="h2">
          Miscellaneous
         </span>
        </p>
        <p class="headingAnchor" id="H3268869630">
         <span class="h3">
          Aspiration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Aspiration during swallowing (known as primary aspiration) is seen in congenital conditions like laryngeal cleft [
         <a href="#rid91">
          91
         </a>
         ], tracheoesophageal fistula, neuromuscular conditions associated with dysphagia [
         <a href="#rid92">
          92,93
         </a>
         ], and some syndromes with swallowing dysfunction [
         <a href="#rid94">
          94
         </a>
         ].
        </p>
        <p>
         Aspiration of refluxed gastric contents (known as secondary aspiration) can be seen in patients with gastroesophageal reflux disease (GERD). In a large study of neurologically normal children, those with GERD had a modestly increased risk for bronchiectasis (OR 2.3, 95% CI 1.7-3.2) [
         <a href="#rid95">
          95
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14537.html" rel="external">
          "Aspiration due to swallowing dysfunction in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5892.html" rel="external">
          "Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents", section on 'Recurrent pneumonia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4291912577">
         <span class="h3">
          Ineffective cough/mucus clearance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Muscular dystrophies and other diseases with neuromuscular weakness are often associated with impaired mucus clearance due to ineffective cough, chest wall deformities, and swallowing dysfunction (causing aspiration), all of which can lead to recurrent pulmonary infection and bronchiectasis. (See
         <a class="medical medical_review" href="/z/d/html/6149.html" rel="external">
          "Duchenne and Becker muscular dystrophy: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5147.html" rel="external">
          "Myotonic dystrophy: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4067733145">
         <span class="h3">
          Systemic autoimmune or inflammatory disorders
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Autoimmune diseases
         </strong>
         – Bronchiectasis has been associated with multiple rheumatic diseases including rheumatoid arthritis, Sjögren's disease, systemic lupus erythematosus, and scleroderma. For example, bronchiectasis is seen on HRCT in 15 to 20 percent of adult patients with rheumatoid arthritis or systemic sclerosis [
         <a href="#rid96">
          96,97
         </a>
         ]. Bronchiectasis is a rare manifestation of these disorders in children and adolescents. The bronchiectasis associated with these disorders may be caused by recurrent aspiration and/or traction in patients with interstitial lung disease. (See
         <a class="medical medical_review" href="/z/d/html/6420.html" rel="external">
          "Childhood-onset systemic lupus erythematosus (SLE): Clinical manifestations and diagnosis", section on 'Pulmonary'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4681.html" rel="external">
          "Pulmonary manifestations of systemic lupus erythematosus in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">
          "Clinical manifestations of Sjögren’s disease: Extraglandular disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sarcoidosis
         </strong>
         – Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that is typically first diagnosed during adolescence or young adulthood. The disease often causes granulomatous inflammation of the bronchial mucosa and peribronchial, perivascular, and subpleural areas of the lung, which can lead to traction bronchiectasis [
         <a href="#rid98">
          98,99
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammatory bowel disease (IBD)
         </strong>
         – The extraintestinal manifestations of IBD occasionally include pulmonary disorders, including chronic bronchitis, bronchiectasis, interstitial lung disease including organizing pneumonia (formerly termed bronchiolitis obliterans organizing pneumonia), and subglottic stenosis. Among children with IBD, bronchiectasis is rare but has been reported [
         <a href="#rid100">
          100-102
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4344.html" rel="external">
          "Pulmonary complications of inflammatory bowel disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5865.html" rel="external">
          "Clinical manifestations and complications of inflammatory bowel disease in children and adolescents", section on 'Extraintestinal manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other interstitial lung diseases
         </strong>
         – Traction bronchiectasis is caused by mechanical traction around the airway due to fibrosis or loss of parenchymal integrity, leading to dilatation of the airway. It can be a complication of several types of diffuse/interstitial lung diseases, although it is much rarer in children compared with adults. (See
         <a class="medical medical_review" href="/z/d/html/6381.html" rel="external">
          "Classification of diffuse lung disease (interstitial lung disease) in infants and children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6374.html" rel="external">
          "Approach to the infant and child with diffuse lung disease (interstitial lung disease)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1841585646">
         <span class="h3">
          Bronchiolitis obliterans
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchiolitis obliterans is usually a postinfectious process (see
         <a class="local">
          'Postinfectious conditions'
         </a>
         above) but is also a relatively common complication of bone marrow transplantation or other solid organ transplants (including lung transplantation), related to chronic rejection. It has also been reported as a manifestation of interstitial lung diseases in children and as a consequence of Stevens-Johnson syndrome [
         <a href="#rid103">
          103
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4654.html" rel="external">
          "Chronic lung allograft dysfunction: Bronchiolitis obliterans syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6381.html" rel="external">
          "Classification of diffuse lung disease (interstitial lung disease) in infants and children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4244733584">
         <span class="h3">
          Environmental exposures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Exposure to household air pollution contributes to chronic lung diseases including bronchiectasis. Pollutants include secondhand tobacco smoke, biomass fuels or coal (which include irritants and particulate matter), and nitrogen dioxide from unvented gas heating [
         <a href="#rid104">
          104
         </a>
         ].
        </p>
        <p>
         Inhaled toxins can lead to acute lung injury and bronchiectasis [
         <a href="#rid105">
          105
         </a>
         ]. Examples include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hydrocarbon inhalation and ingestion [
         <a href="#rid106">
          106
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic inhalation of ammonia, talc, silicate, or coal dust [
         <a href="#rid107">
          107-109
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic inhalation of mineral oils like paraffin (leading to lipoid pneumonia that progresses to bronchiectasis) [
         <a href="#rid110">
          110
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exposure to arsenic in drinking water [
         <a href="#rid111">
          111
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H663751606">
         <span class="h3">
          Genetic syndromes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchiectasis has been associated with a variety of genetic disorders, likely representing different genetic mechanisms that predispose to lung injury [
         <a href="#rid112">
          112,113
         </a>
         ]. Clinical syndromes in which bronchiectasis is a prominent feature include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cartilage deficiency
         </strong>
         (Williams-Campbell syndrome;
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F211450&amp;token=tEpDslnpc0F0kICl%2Fz7sFZpszKvOtG3bo7mRUx02%2BlZIdwLqHguN%2BGsYjcILt0Xf&amp;TOPIC_ID=6358" target="_blank">
          MIM 211450
         </a>
         ) – This is a rare congenital disorder characterized by deficient cartilage in the bronchial tree, causing generalized tracheomalacia [
         <a href="#rid114">
          114,115
         </a>
         ]. Because the bronchial cartilage is absent or deficient, the segmental and subsegmental bronchi are dilated and collapse easily. Children typically present before three years of age with cough, wheezing, and recurrent febrile illness. Based on the few cases reported in the literature, the prognosis is variable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital tracheobronchomegaly
         </strong>
         (Mounier-Kuhn syndrome) – This is a congenital disorder that is characterized by markedly dilated trachea and main bronchi, resulting in dynamic dilation and collapse during inspiration and exhalation [
         <a href="#rid116">
          116
         </a>
         ]. Outpouching of redundant mucosal tissue results in pooling of secretions and recurrent atelectasis and pneumonia, leading to bronchiectasis [
         <a href="#rid117">
          117
         </a>
         ]. The clinical manifestations range from minimal disease to respiratory failure and death. Diagnostic criteria for adults on imaging are transverse tracheal diameter &gt;30 mm, right mainstem bronchus &gt;24 mm, and left mainstem bronchus &gt;23 mm [
         <a href="#rid118">
          118
         </a>
         ]. On pathologic examination, there is atrophy or absence of elastic tissue as well as thinning of the muscular components of the airway. (See
         <a class="medical medical_review" href="/z/d/html/4406.html" rel="external">
          "Tracheomalacia in adults: Clinical features and diagnostic evaluation", section on 'Congenital (tracheomegaly)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Other genetic disorders that are occasionally associated with bronchiectasis include (among many others):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Marfan syndrome
         </strong>
         – Marfan syndrome is an inherited abnormality of connective tissue that is occasionally complicated by bronchiectasis [
         <a href="#rid119">
          119
         </a>
         ]. It is postulated that bronchiectasis develops due to intrinsic bronchial wall defect from fibrillin-1 degeneration or due to the higher risk of recurrent lung infections if chest wall deformities are present [
         <a href="#rid120">
          120
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8150.html" rel="external">
          "Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Yellow nail syndrome
         </strong>
         (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F153300&amp;token=tEpDslnpc0F0kICl%2Fz7sFdq7KW313yBvat27CnEqDw8TwSBaC%2Fgw5KR1jq97H3tn&amp;TOPIC_ID=6358" target="_blank">
          MIM %153300
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">
          "Overview of nail disorders", section on 'Yellow nail syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Autosomal dominant polycystic kidney disease
         </strong>
         (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F173900&amp;token=tEpDslnpc0F0kICl%2Fz7sFRpMsbswgmBJuV5MFhYv5gB7QYmXVK5uOKY6UtnL57BZ&amp;TOPIC_ID=6358" target="_blank">
          MIM #173900
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F613095&amp;token=tEpDslnpc0F0kICl%2Fz7sFSbCnKy1I6QPXy4E96e7Dz4TnSqQ5NReGEvzU711Wlqn&amp;TOPIC_ID=6358" target="_blank">
          MIM #613095
         </a>
         ) [
         <a href="#rid121">
          121,122
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15319.html" rel="external">
          "Autosomal dominant polycystic kidney disease (ADPKD) in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Syndromes associated with immune deficiency
         </strong>
         (eg, ataxia-telangiectasia, DiGeorge syndrome). (See
         <a class="local">
          'Hereditary'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1268975015">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Bronchiectasis was once considered rare in children but is increasingly recognized over the last two decades, likely primarily due to increasing awareness of the condition and availability of sensitive diagnostic methods such as multidetector high-resolution CT (HRCT). (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         – The pathogenesis of bronchiectasis usually involves a combination of chronic or recurrent infection, airway inflammation, and airway obstruction and/or impaired mucociliary clearance, interacting in a vicious cycle that causes progressive damage to the lower airway structure. (See
         <a class="local">
          'Pathophysiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes
         </strong>
         – The relative prevalence of different causes of bronchiectasis in children varies substantially depending on the population studied. Important considerations include  (
         <a class="graphic graphic_table graphicRef87712" href="/z/d/graphic/87712.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Postinfectious
         </strong>
         – Including protracted bacterial bronchitis (PBB); specific infections including tuberculosis, pertussis, and measles; and postinfectious bronchiolitis obliterans (PIBO). (See
         <a class="local">
          'Postinfectious conditions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Bronchial narrowing or obstruction
         </strong>
         – Including pulmonary airway anomalies, foreign body aspiration, and mucoid impaction. (See
         <a class="local">
          'Bronchial narrowing or obstruction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Immunodeficiencies
         </strong>
         – Including primary immunodeficiencies (eg, common variable immunodeficiency) or acquired immunodeficiencies (HIV or pharmacologic immunosuppression). (See
         <a class="local">
          'Immunodeficiencies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Impaired mucociliary clearance
         </strong>
         – In cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). (See
         <a class="local">
          'Impaired mucociliary clearance'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other
         </strong>
         – Other causes include chronic aspiration (eg, in neurologic disorders), ineffective cough (eg, in neuromuscular disorders), systemic autoimmune or inflammatory disorders (eg, systemic lupus erythematosus), post-transplant bronchiolitis obliterans, or environmental exposures (toxic inhalations). (See
         <a class="local">
          'Miscellaneous'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1322466527">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Khoulood Fakhoury, MD, and Adaobi Kanu, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Goyal V, Chang AB. Bronchiectasis in Childhood. Clin Chest Med 2022; 43:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chalmers JD, Chang AB, Chotirmall SH, et al. Bronchiectasis. Nat Rev Dis Primers 2018; 4:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet 2018; 392:866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodd JD, Souza CA, Müller NL. Conventional high-resolution CT versus helical high-resolution MDCT in the detection of bronchiectasis. AJR Am J Roentgenol 2006; 187:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill LE, Ritchie G, Wightman AJ, et al. Comparison between conventional interrupted high-resolution CT and volume multidetector CT acquisition in the assessment of bronchiectasis. Br J Radiol 2010; 83:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapur N, Masel JP, Watson D, et al. Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: need to redefine bronchial dilatation. Chest 2011; 139:1445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Fortescue R, Grimwood K, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J 2021; 58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chotirmall SH, Chalmers JD. Bronchiectasis: an emerging global epidemic. BMC Pulm Med 2018; 18:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCallum GB, Binks MJ. The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents. Front Pediatr 2017; 5:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Säynäjäkangas O, Keistinen T, Tuuponen T, Kivelä SL. Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register. Cent Eur J Public Health 1998; 6:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Twiss J, Metcalfe R, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005; 90:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis [obstructive airways disease]. Clin Pulm Med 2005; 12:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karadag B, Karakoc F, Ersu R, et al. Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration 2005; 72:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Health 2019; 7:e1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar A, Lodha R, Kumar P, Kabra SK. Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome. Indian Pediatr 2015; 52:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singleton RJ, Valery PC, Morris P, et al. Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Pediatr Pulmonol 2014; 49:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Masel JP, Boyce NC, et al. Non-CF bronchiectasis: clinical and HRCT evaluation. Pediatr Pulmonol 2003; 35:477.
          </a>
         </li>
         <li class="breakAll">
          Barnard LT, Zhang J, Asthma and Respiratory Foundation New Zealand. The impact of respiratory disease in New Zealand: 2020 update. 2021. Available at: https://www.asthmafoundation.org.nz/assets/documents/Respiratory-Impact-report-final-2021Aug11.pdf (Accessed on June 17, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waite DA, Wakefield SJ, Mackay JB, Ross IT. Mucociliary transport and ultrastructural abnormalities in Polynesian bronchiectasis. Chest 1981; 80:896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCallum GB, Oguoma VM, Versteegh LA, et al. Comparison of Profiles of First Nations and Non-First Nations Children With Bronchiectasis Over Two 5-Year Periods in the Northern Territory, Australia. Chest 2021; 160:1200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCallum GB, Chang AB. 'Good enough' is 'not enough' when managing indigenous adults with bronchiectasis in Australia and New Zealand. Respirology 2018; 23:725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munro KA, Reed PW, Joyce H, et al. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr Pulmonol 2011; 46:131.
          </a>
         </li>
         <li class="breakAll">
          Australian Institute of Health and Welfare. Bronchiectasis. 2020. Available at: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/bronchiectasis/contents/deaths (Accessed on July 13, 2022).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. CDC Wonder: About Underlying Cause of Death, 1999-2020. Available at: http://wonder.cdc.gov/ucd-icd10.html (Accessed on July 13, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smaldone GC, Messina MS. Flow limitation, cough, and patterns of aerosol deposition in humans. J Appl Physiol (1985) 1985; 59:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Redding GJ, Kishioka C, Martinez P, Rubin BK. Physical and transport properties of sputum from children with idiopathic bronchiectasis. Chest 2008; 134:1129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson R, Roberts D, Cole P. Effect of bacterial products on human ciliary function in vitro. Thorax 1985; 40:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goyal V, Grimwood K, Marchant J, et al. Pediatric bronchiectasis: No longer an orphan disease. Pediatr Pulmonol 2016; 51:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizzutto SJ, Yerkovich ST, Upham JW, et al. Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae. PLoS One 2014; 9:e104236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hodge S, Upham JW, Pizzutto S, et al. Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Chest 2016; 149:508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizzutto SJ, Hare KM, Upham JW. Bronchiectasis in Children: Current Concepts in Immunology and Microbiology. Front Pediatr 2017; 5:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cole PJ. Inflammation: a two-edged sword--the model of bronchiectasis. Eur J Respir Dis Suppl 1986; 147:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Redding GJ, Everard ML. Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr Pulmonol 2008; 43:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Upham JW, Masters IB, et al. Protracted bacterial bronchitis: The last decade and the road ahead. Pediatr Pulmonol 2016; 51:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           WHITWELL F. A study of the pathology and pathogenesis of bronchiectasis. Thorax 1952; 7:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaga M, Bentley AM, Humbert M, et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998; 53:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regamey N, Ochs M, Hilliard TN, et al. Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2008; 177:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           REID LM. Reduction in bronchial subdivision in bronchiectasis. Thorax 1950; 5:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapur N, Stroil-Salama E, Morgan L, et al. Factors associated with "Frequent Exacerbator" phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry. Respir Med 2021; 188:106627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eastham KM, Fall AJ, Mitchell L, Spencer DA. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004; 59:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol 2003; 47:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J 2005; 26:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizzutto SJ, Grimwood K, Bauert P, et al. Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis. Pediatr Pulmonol 2013; 48:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haidopoulou K, Calder A, Jones A, et al. Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol 2009; 44:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           King PT, Holdsworth SR, Freezer NJ, et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006; 100:2183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162:1277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           King PT, Holdsworth SR, Farmer M, et al. Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood. COPD 2009; 6:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brower KS, Del Vecchio MT, Aronoff SC. The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects. BMC Pediatr 2014; 14:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Satırer O, Mete Yesil A, Emiralioglu N, et al. A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience. Respir Med 2018; 137:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eralp EE, Gokdemir Y, Atag E, et al. Changing clinical characteristics of non-cystic fibrosis bronchiectasis in children. BMC Pulm Med 2020; 20:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Habesoglu MA, Ugurlu AO, Eyuboglu FO. Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis. Ann Thorac Med 2011; 6:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nikolaizik WH, Warner JO. Aetiology of chronic suppurative lung disease. Arch Dis Child 1994; 70:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapur N, Masters IB, Chang AB. Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations. Respir Med 2009; 103:1681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Grady KF, Cripps AW, Grimwood K. Paediatric and adult bronchiectasis: Vaccination in prevention and management. Respirology 2019; 24:107.
          </a>
         </li>
         <li class="breakAll">
          O’Toole RF. Tuberculosis as an underlying etiological factor for other human respiratory diseases. In: Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions, Hasnain SE, Ehtesham NZ, Grover S (Eds), Springer Singapore, 2019. p.17.
         </li>
         <li class="breakAll">
          Goyal V, Chang AB, Marchant JM. Bronchiectasis in childhood (including PBB). In: Encyclopedia of Respiratory Medicine, 2nd ed, Janes SM (Ed), Academic Press, 2022. p.208.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wurzel DF, Marchant JM, Yerkovich ST, et al. Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for Bronchiectasis. Chest 2016; 150:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruffles TJC, Marchant JM, Masters IB, et al. Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study. Respirology 2021; 26:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braz M, Ferreira AC, Sousa AS, Barata F. Post-infective bronchiectasis by measles prior infection - A case report. Respir Med Case Rep 2019; 26:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaschula RO, Druker J, Kipps A. Late morphologic consequences of measles: a lethal and debilitating lung disease among the poor. Rev Infect Dis 1983; 5:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montella S, De Stefano S, Sperlì F, et al. Increased risk of chronic suppurative lung disease after measles or pertussis in non-vaccinated children. Vaccine 2007; 25:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alharbi S, Van Caeseele P, Consunji-Araneta R, et al. Epidemiology of severe pediatric adenovirus lower respiratory tract infections in Manitoba, Canada, 1991-2005. BMC Infect Dis 2012; 12:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wurzel DF, Mackay IM, Marchant JM, et al. Adenovirus species C is associated with chronic suppurative lung diseases in children. Clin Infect Dis 2014; 59:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim CK, Chung CY, Kim JS, et al. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics 2000; 105:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao C, Liu J, Yang H, et al. Mycoplasma pneumoniae-Associated Bronchiolitis Obliterans Following Acute Bronchiolitis. Sci Rep 2017; 7:8478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arora A, Bhalla AS, Jana M, Sharma R. Overview of airway involvement in tuberculosis. J Med Imaging Radiat Oncol 2013; 57:576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol 2001; 32:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krishnan S, Kniese CM, Mankins M, et al. Management of broncholithiasis. J Thorac Dis 2018; 10:S3419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pursner M, Haller JO, Berdon WE. Imaging features of Mycobacterium avium-intracellulare complex (MAC) in children with AIDS. Pediatr Radiol 2000; 30:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valery PC, Torzillo PJ, Mulholland K, et al. Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 2004; 23:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee E, Young Lee Y. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance. Respir Med 2020; 175:106209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu PQ, Li X, Jiang WH, et al. Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children. Springerplus 2016; 5:1622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jerkic SP, Koc-Günel S, Herrmann E, et al. Long-term course of bronchial inflammation and pulmonary function testing in children with postinfectious bronchiolitis obliterans. Pediatr Pulmonol 2021; 56:2966.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas R, Chang A, Masters IB, et al. Association of childhood tracheomalacia with bronchiectasis: a case-control study. Arch Dis Child 2022; 107:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karakoç F, Karadağ B, Akbenlioğlu C, et al. Foreign body aspiration: what is the outcome? Pediatr Pulmonol 2002; 34:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sirmali M, Türüt H, Kisacik E, et al. The relationship between time of admittance and complications in paediatric tracheobronchial foreign body aspiration. Acta Chir Belg 2005; 105:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karakoc F, Cakir E, Ersu R, et al. Late diagnosis of foreign body aspiration in children with chronic respiratory symptoms. Int J Pediatr Otorhinolaryngol 2007; 71:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soyer O, Ozen C, Cavkaytar O, et al. Right middle lobe atelectasis in children with asthma and prognostic factors. Allergol Int 2016; 65:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sekerel BE, Nakipoglu F. Middle lobe syndrome in children with asthma: review of 56 cases. J Asthma 2004; 41:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altamirano HG, McGeady SJ, Mansmann HC Jr. Right middle lobe syndrome in asthmatic children. Pediatr Asthma Allergy Immunol 1991; 5:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jat KR, Vaidya PC, Mathew JL, et al. Childhood allergic bronchopulmonary aspergillosis. Lung India 2018; 35:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qiabi M, Chagnon K, Beaupré A, et al. Scoliosis and bronchial obstruction. Can Respir J 2015; 22:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Domínguez O, Giner MT, Alsina L, et al. [Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol]. An Pediatr (Barc) 2012; 76:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aghamohammadi A, Abolhassani H, Biglari M, et al. Analysis of switched memory B cells in patients with IgA deficiency. Int Arch Allergy Immunol 2011; 156:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berman DM, Mafut D, Djokic B, et al. Risk factors for the development of bronchiectasis in HIV-infected children. Pediatr Pulmonol 2007; 42:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dronamraju V, Singh N, Poon J, et al. Assessment of Bronchiectasis in HIV Patients among an Urban Population. Case Rep Pulmonol 2020; 2020:8903809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dury S, Colosio C, Etienne I, et al. Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. BMC Pulm Med 2015; 15:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Çolak Y, Nordestgaard BG, Afzal S. Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population. Eur Respir J 2020; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller AC, Comellas AP, Hornick DB, et al. Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions. Proc Natl Acad Sci U S A 2020; 117:1621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arya AK, Beer HL, Benton J, et al. Does Young's syndrome exist? J Laryngol Otol 2009; 123:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnston DR, Watters K, Ferrari LR, Rahbar R. Laryngeal cleft: evaluation and management. Int J Pediatr Otorhinolaryngol 2014; 78:905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piccione JC, McPhail GL, Fenchel MC, et al. Bronchiectasis in chronic pulmonary aspiration: risk factors and clinical implications. Pediatr Pulmonol 2012; 47:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuladi A, Suresh S, Thomas R, et al. Multidisciplinary approach to paediatric aerodigestive disorders: A single-centre longitudinal observational study. J Paediatr Child Health 2020; 56:1929.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pitney AC, Callahan CW, Ruess L. Reversal of bronchiectasis caused by chronic aspiration in cri du chat syndrome. Arch Dis Child 2001; 85:413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Serag HB, Gilger M, Kuebeler M, Rabeneck L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology 2001; 121:1294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin LW, Prisco LC, Huang W, et al. Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2021; 51:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith R, Harrison M, Lam KV, et al. The emerging association between bronchiectasis and systemic sclerosis: assessing prevalence and potential causality. Intern Med J 2023; 53:1204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hiles PD, Kemp KR, Coviello JM. Diffuse bronchiectasis as the primary manifestation of endobronchial sarcoidosis. Respir Med Case Rep 2017; 20:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sawahata M, Shijubo N, Johkoh T, et al. Honeycomb lung-like structures resulting from clustering of traction bronchiectasis distally in sarcoidosis. Respirol Case Rep 2020; 8:e00539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peradzyńska J, Krenke K, Lange J, et al. Low prevalence of pulmonary involvement in children with inflammatory bowel disease. Respir Med 2012; 106:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russi A, Gurbani N, Rosen MJ, et al. Pediatric Patient With Ulcerative Colitis-Associated Bronchiectasis. ACG Case Rep J 2020; 7:e00365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jochmann A, Trachsel D, Hammer J. Inflammatory bowel disease and the lung in paediatric patients. Breathe (Sheff) 2021; 17:200269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seccombe EL, Ardern-Jones M, Walker W, et al. Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Clin Exp Dermatol 2019; 44:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med 2014; 2:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persichini R, Allou N, Allyn J, et al. Near-Fatal Lung Injury with Rapid-Onset Bronchiectasis Caused by Traditional Fumigation Therapy on the French Island of Mayotte. Ann Am Thorac Soc 2017; 14:1041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banjar H. Bronchiectasis after Kerosene Ingestion. Bahrain Medical Bulletin 1998; 20:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tonelli AR, Pham A. Bronchiectasis, a long-term sequela of ammonia inhalation: a case report and review of the literature. Burns 2009; 35:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verlynde G, Agneessens E, Dargent JL. Pulmonary Talcosis Due to Daily Inhalation of Talc Powder. J Belg Soc Radiol 2018; 102:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doganay S, Gocmen H, Yikilmaz A, Coskun A. Silicosis due to Denim Sandblasting in Young People: MDCT Findings. Eurasian J Med 2010; 42:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cozzi D, Bindi A, Cavigli E, et al. Exogenous lipoid pneumonia: when radiologist makes the difference. Radiol Med 2021; 126:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazumder DN, Steinmaus C, Bhattacharya P, et al. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology 2005; 16:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gould CM, Freeman AF, Olivier KN. Genetic causes of bronchiectasis. Clin Chest Med 2012; 33:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nikolic A. Pathophysiology and Genetics of Bronchiectasis Unrelated to Cystic Fibrosis. Lung 2018; 196:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams HE, Landau LI, Phelan PD. Generalized bronchiectasis due to extensive deficiency of bronchial cartilage. Arch Dis Child 1972; 47:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones VF, Eid NS, Franco SM, et al. Familial congenital bronchiectasis: Williams-Campbell syndrome. Pediatr Pulmonol 1993; 16:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon M, Vremaroiu P, Andrei F. Mounier-Kuhn syndrome. J Bronchology Interv Pulmonol 2014; 21:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akgedik R, Karamanli H, Kizilirmak D, et al. Mounier-Kuhn syndrome (tracheobronchomegaly): An analysis of eleven cases. Clin Respir J 2018; 12:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           KATZ I, LEVINE M, HERMAN P. Tracheobronchiomegaly. The Mounier-Kuhn syndrome. Am J Roentgenol Radium Ther Nucl Med 1962; 88:1084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teoh PC. Bronchiectasis and spontaneous pneumothorax in Marfan's syndrome. Chest 1977; 72:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tun MH, Borg B, Godfrey M, et al. Respiratory manifestations of Marfan syndrome: a narrative review. J Thorac Dis 2021; 13:6012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moua T, Zand L, Hartman RP, et al. Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. PLoS One 2014; 9:e93674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Laecke S, Van Biesen W. Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes. Clin Kidney J 2021; 14:746.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6358 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35236563" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Bronchiectasis in Childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30442957" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30215382" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Bronchiectasis in children: diagnosis and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16861546" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Conventional high-resolution CT versus helical high-resolution MDCT in the detection of bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19505963" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Comparison between conventional interrupted high-resolution CT and volume multidetector CT acquisition in the assessment of bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20864608" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: need to redefine bronchial dilatation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33542057" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29788944" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Bronchiectasis: an emerging global epidemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28265556" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9787927" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15871981" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : New Zealand national incidence of bronchiectasis "too high" for a developed country.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Prevalence and economic burden of bronchiectasis [obstructive airways disease]
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15942290" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31402007" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25638182" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23401398" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12746947" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Non-CF bronchiectasis: clinical and HRCT evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12746947" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Non-CF bronchiectasis: clinical and HRCT evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7307632" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Mucociliary transport and ultrastructural abnormalities in Polynesian bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33964302" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Comparison of Profiles of First Nations and Non-First Nations Children With Bronchiectasis Over Two 5-Year Periods in the Northern Territory, Australia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29532561" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : 'Good enough' is 'not enough' when managing indigenous adults with bronchiectasis in Australia and New Zealand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20717910" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20717910" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20717910" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4030604" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Flow limitation, cough, and patterns of aerosol deposition in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18753467" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Physical and transport properties of sputum from children with idiopathic bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3919460" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Effect of bacterial products on human ciliary function in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26840008" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Pediatric bronchiectasis: No longer an orphan disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25111142" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26867834" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28611970" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Bronchiectasis in Children: Current Concepts in Immunology and Microbiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3533593" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Inflammation: a two-edged sword--the model of bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18435475" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26636654" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Protracted bacterial bronchitis: The last decade and the road ahead.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12984409" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : A study of the pathology and pathogenesis of bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9828857" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18218992" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14776716" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Reduction in bronchial subdivision in bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34592538" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Factors associated with "Frequent Exacerbator" phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15047953" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The need to redefine non-cystic fibrosis bronchiectasis in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12927665" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15994383" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22431241" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19514055" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16650970" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Characterisation of the onset and presenting clinical features of adult bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11029331" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : An investigation into causative factors in patients with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19378226" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25492164" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29605210" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32546272" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Changing clinical characteristics of non-cystic fibrosis bronchiectasis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21760844" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8129439" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Aetiology of chronic suppurative lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19501498" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30477047" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Paediatric and adult bronchiectasis: Vaccination in prevention and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30477047" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Paediatric and adult bronchiectasis: Vaccination in prevention and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30477047" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Paediatric and adult bronchiectasis: Vaccination in prevention and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27400908" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for Bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33045125" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30723668" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Post-infective bronchiectasis by measles prior infection - A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6308746" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Late morphologic consequences of measles: a lethal and debilitating lung disease among the poor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17034906" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Increased risk of chronic suppurative lung disease after measles or pertussis in non-vaccinated children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22414179" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Epidemiology of severe pediatric adenovirus lower respiratory tract infections in Manitoba, Canada, 1991-2005.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24748519" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Adenovirus species C is associated with chronic suppurative lung diseases in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10654958" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28814783" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Mycoplasma pneumoniae-Associated Bronchiolitis Obliterans Following Acute Bronchiolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24119272" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Overview of airway involvement in tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11477735" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Bronchiectasis: still a problem.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30505529" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Management of broncholithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10876832" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Imaging features of Mycobacterium avium-intracellulare complex (MAC) in children with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15602188" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33186845" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27722041" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34156164" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Long-term course of bronchial inflammation and pulmonary function testing in children with postinfectious bronchiolitis obliterans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34649867" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Association of childhood tracheomalacia with bronchiectasis: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12112794" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Foreign body aspiration: what is the outcome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16438074" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : The relationship between time of admittance and complications in paediatric tracheobronchial foreign body aspiration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17125849" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Late diagnosis of foreign body aspiration in children with chronic respiratory symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26806056" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Right middle lobe atelectasis in children with asthma and prognostic factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15281327" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Middle lobe syndrome in children with asthma: review of 56 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Right middle lobe syndrome in asthmatic children
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30381560" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Childhood allergic bronchopulmonary aspergillosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26083538" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Scoliosis and bronchial obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22240193" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : [Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21832837" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Analysis of switched memory B cells in patients with IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17722116" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Risk factors for the development of bronchiectasis in HIV-infected children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32181043" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Assessment of Bronchiectasis in HIV Patients among an Urban Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26545860" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32398304" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31882447" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19128521" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Does Young's syndrome exist?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24735606" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Laryngeal cleft: evaluation and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22028069" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Bronchiectasis in chronic pulmonary aspiration: risk factors and clinical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32886957" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Multidisciplinary approach to paediatric aerodigestive disorders: A single-centre longitudinal observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11668107" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Reversal of bronchiectasis caused by chronic aspiration in cri du chat syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11729108" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34450505" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34894170" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : The emerging association between bronchiectasis and systemic sclerosis: assessing prevalence and potential causality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27896060" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Diffuse bronchiectasis as the primary manifestation of endobronchial sarcoidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32166034" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Honeycomb lung-like structures resulting from clustering of traction bronchiectasis distally in sarcoidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22516040" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Low prevalence of pulmonary involvement in children with inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32548193" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Pediatric Patient With Ulcerative Colitis-Associated Bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34295391" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Inflammatory bowel disease and the lung in paediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30908698" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25193349" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Respiratory risks from household air pollution in low and middle income countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28398079" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Near-Fatal Lung Injury with Rapid-Onset Bronchiectasis Caused by Traditional Fumigation Therapy on the French Island of Mayotte.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Bronchiectasis after Kerosene Ingestion
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18538935" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Bronchiectasis, a long-term sequela of ammonia inhalation: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30039026" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Pulmonary Talcosis Due to Daily Inhalation of Talc Powder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25610113" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Silicosis due to Denim Sandblasting in Young People: MDCT Findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32451884" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Exogenous lipoid pneumonia: when radiologist makes the difference.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16222165" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22640844" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Genetic causes of bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29754320" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Pathophysiology and Genetics of Bronchiectasis Unrelated to Cystic Fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5034672" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Generalized bronchiectasis due to extensive deficiency of bronchial cartilage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8265276" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Familial congenital bronchiectasis: Williams-Campbell syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24739689" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Mounier-Kuhn syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28026118" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Mounier-Kuhn syndrome (tracheobronchomegaly): An analysis of eleven cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13958486" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Tracheobronchiomegaly. The Mounier-Kuhn syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/913156" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Bronchiectasis and spontaneous pneumothorax in Marfan's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34795948" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Respiratory manifestations of Marfan syndrome: a narrative review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24747723" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33777359" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
